IBM's Stock Heads Month in 34 Years Amid Claude Code Threat
IBM's shares sank as Anthropic's Claude Code intensifies AI competition, pushing ibm’s stock heads worst for a month ...
When Does Automatic Rebalancing Trigger
Triggers typically occur when portfolio drift exceeds a set threshold or on a scheduled interval, prompting a rebalance to restore targets.
15,940 articles
Universal (UVE) 2025 Earnings: What Investors Should Know
As the quarterly earnings cycle wraps, universal (uve) 2025 earnings take center stage for growth-focused investors. ...
326%, Should Micron Technology Be on Your Radar Now?
Micron Technology soared 326% in just 12 months, but a sky-high gain doesn’t guarantee a smart buy. This guide breaks...
China Holdings Sells Over: Yum China CEO Sells 100k Shares
When a top executive at Yum China sells a large block of stock, investors pay attention. This article breaks down the...
DNOW Stock Lands New Stake Amid 18% Drop, Investors React
A notable $25.7 million position in DNOW signals institutional confidence despite an 18% drop last year. This article...
Goodnow Investment Group Boosts Instacart Stake Position
A rising stake in Instacart highlights how investment groups are pricing the shift to digital grocery. This article e...
Suro Capital (SSSS) 2025 Q4 Earnings Deep Dive
As SuRo Capital releases its Q4 2025 results, investors need a clear playbook. This deep dive breaks down the key met...
Xpeng Stock Winning This Week Signals Growth in EV
Investors are buzzing about XPeng as xpeng stock winning this week suggests growth catalysts could unfold. This guide...
Oracle Just Posted Best Quarter; 2026 Could Get Even Better
Oracle just posted best quarter in years, powered by cloud and AI demand. This article breaks down what changed, why ...
What CFTC’s Guidance Actually Reshapes Crypto Rules
A landmark joint interpretive guidance from the SEC and CFTC clarifies crypto regulation, focusing on security classi...
Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Arm's Chip Game Changer: Is It Time to Buy ARM Stock Now
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status